Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide
Karl Jablonowski1, Brian Hooker1
1Children's Health Defense, Washington, DC, USA.
Abstract:
Andersson et al. published "Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study" with a discussion and conclusion that contradict the data. Aluminum adjuvant safety studies are largely underwhelming, irrelevant to injectable aluminum, and are not designed to study neurodevelopmental disorders. The manuscript matches the original supplemental, in which many neurodevelopmental diagnoses were deleted, but not the updated supplemental, which shows an association with neurodevelopmental disorder. Neurodevelopmental disorders such as Asperger syndrome (now Level 1 autism spectrum disorder), other pervasive developmental disorders, autistic disorder, and autism spectrum disorder are all found to be statistically significantly associated with a higher cumulative dose of vaccine-derived aluminum.
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:19Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.